Updated on Jun 30, 2022 | Featured, Insights
The consequences of repealing the Affordable Care Act, better known as Obamacare, extend far beyond the individual insurance market. Repeal could also have enormous implications for state budgets and hospital payments. Jeopardizing any one of these important things is troublesome enough, but harming all three simultaneously would severely strain the nation’s healthcare delivery system. Read more
Nov 1, 2016 | Insights
Outrage over repeated hikes in the price of lifesaving EpiPens is the latest example of pharmaceutical companies breaking the social contract with patients who rely upon their medicines. Just as hospitals have an ethical commitment to treat patients regardless of their ability to pay, pharmaceutical companies have a similar obligation to ensure those who have a medical necessity for a drug are able to receive it. Yet many Americans must do without the medicines they need because of the prohibitive cost, even with the coupons and discounts drug marketers offer. Not only is this morally indefensible, but, as a consequence, society must also bear the expense of medical treatments that become necessary because patients fail to obtain drugs that could improve their health. We feel the impact every day at our hospital emergency rooms. Read More
Oct 7, 2016 | Insights
As a psychiatrist who has spent much of my career researching schizophrenia and other mental disorders, I am acutely aware of a major flaw in our health system: the need for behavioral health care far outweighs its availability, in part because our system does not value or pay for it on par with medical and surgical care.
Read the article
Sep 2, 2016 | Insights
In our advanced technological age, where computers make it possible to sequence the entire human genome and use that data to customize life-saving cancer treatments, we still ignore the power of even the most basic computing to dramatically increase efficiency on the administrative side of healthcare.
Read the article
Updated on Jun 30, 2022 | Inside, Insights
Members of the Mount Sinai panel included, from left, Ross L. Cagan, PhD, Director, Center for Personalized Cancer Therapeutics; Matthew Galsky, MD, Director of Genitourinary Medical Oncology; Joshua Brody, MD, Director, Lymphoma Immunotherapy Program; Steven J. Burakoff, MD, Director of The Tisch Cancer Institute; and Kenneth L. Davis, MD, President and Chief Executive Officer, Mount Sinai Health System.
At the 2016 Aspen Ideas Festival, a public gathering dedicated to the global exchange of ideas, faculty and staff from the Mount Sinai Health System provided attendees with complimentary skin cancer and heart health screenings, and participated in panel discussions on topics that included drug prices, living organ donations, gene-editing technologies, and ways to improve health care globally. The festival is presented by the Aspen Institute in partnership with The Atlantic magazine.
In a panel discussion on “Cancer Breakthroughs: The Promise of New Treatments,” specialists from the Mount Sinai Health System discussed significant advances being made in personalized vaccines and immunotherapies. The Tisch Cancer Institute at the Icahn School of Medicine at Mount Sinai is involved in clinical trials that are exploring multiple approaches to immunotherapy, including intratumoral injections that are being used in combination with traditional treatments, such as surgery, radiation, and chemotherapy. (more…)
Updated on Jun 30, 2022 | Insights
The search for medicines that can prevent Alzheimer’s disease is showing more promise than ever, thanks in part to human genome mapping and advanced brain scanning capabilities. Yet, as scientists utilize new capabilities to peel away at the onion holding the answers to Alzheimer’s, they’re discovering the onion is larger than it had appeared.
Read the article
The consequences of repealing the Affordable Care Act, better known as Obamacare, extend far beyond the individual insurance market. Repeal could also have enormous implications for state budgets and hospital payments. Jeopardizing any one of these important things is troublesome enough, but harming all three simultaneously would severely strain the nation’s healthcare delivery system. Read more
